Cancer research
A new study highlights the growing potential of nanoparticle-mediated cancer therapeutics, offering a promising solution to the global health concern of cancer. According to research from Saveetha School of Engineering, cancer is responsible for one in six deaths worldwide, making it a major global health concern. Traditional treatment approaches, such
Cancer
A recent case report has shed new light on the diagnosis and treatment of multiple myeloma, a rare and aggressive form of cancer. The research, published in Frontiers in Oncology, detailed the case of a patient who experienced a relapse of multiple myeloma in the central nervous system (CNS) after
Cancer
Researchers at the University of Texas MD Anderson Cancer Center have made a breakthrough in understanding the optimal time point for monitoring human papillomavirus (HPV) circulating tumor DNA (ctDNA) as a prognostic biomarker for localized anal cancer. According to the study, detecting HPV ctDNA three months after chemoradiation is associated
Cancer
Researchers at the University of Texas MD Anderson Cancer Center have reported significant advancements in the treatment of central nervous system (CNS) tumors, specifically in the area of endovascular neurointerventional techniques. According to the study, the past 25 years have seen limited progress in treating CNS tumors, with dismal outcomes
Cancer
A team of researchers from Wuhan University has published a study in the IEEE Journal of Biomedical and Health Informatics, showcasing a novel method for prioritizing personalized cancer driver genes based on higher-order interactions among genes. This breakthrough approach, known as PITCH, has the potential to revolutionize cancer therapy by
Genetic research
Researchers at Mansoura University in Egypt have made a significant discovery in the field of personalized medicine, shedding light on the impact of genetic variations on the response to chemotherapy in patients with chronic lymphocytic leukemia (CLL). The study, published in the journal Frontiers in Bioscience-Scholar, found that variations in
Genetic research
Research has shown that combining pre-treatment MRI-derived radiomic features with clinical data improves the accuracy of predicting biochemical recurrence-free survival (BCRFS) after prostate radiotherapy. This retrospective cohort analysis included patients with biopsy-proven prostate cancer who received radiotherapy between 2007 and 2013 at two cancer centers in the UK. The study
Cancer
A new study published in Acta Pharmaceutica Sinica B has made significant strides in cancer gene therapy. Researchers from the College of Pulmonary and Critical Care Medicine, Chinese People's Liberation Army (PLA) General Hospital, have developed submicron-sized biomimetic liposomes that effectively target and treat metastatic lung cancer. The
Genetic research
Researchers at Nanjing University have made a groundbreaking discovery in the field of gene therapy, identifying NR4A3 as a crucial factor in suppressing bladder cancer progression. According to the study published in European Journal of Histochemistry, NR4A3 overexpression inhibits bladder cancer cell proliferation, migration, and invasion, while promoting apoptosis. The
Cancer
Researchers at the University of Cambridge have identified key challenges facing nanomedicine in cancer treatment, highlighting the need for a re-examination of nanoparticle pharmacokinetics, optimization of dosing regimens, and solutions to antigen depletion to realize the full potential of nanomedicine. Despite recent advances in targeted drug delivery, clinical trials of
Genetic research
Scientists at the University of Nebraska Medical Center have made a groundbreaking discovery in the field of oncology, revealing new insights into the genetic drivers of angioimmunoblastic T-cell lymphoma (AITL). Using a comprehensive approach that combined whole-exome sequencing, transcriptomic analysis, and methylation analysis, the researchers identified several key mutations that
Genetic research
Researchers at Fudan University Shanghai Cancer Center have developed a radiomics method using magnetic resonance imaging (MRI) to predict FOXA1 gene mutations in prostate cancer patients. The study, published in Scientific Reports, focused on analyzing clinicoradiological and MRI radiomics data from 367 prostate cancer patients to identify features associated with
